Abstract #0140

Mechanism of recovery following stem cell therapy in ischemic stroke: cell or secretome?

Shannon Helsper^1,2, Xuegang Yuan³, Richard Jeske², Li Sun⁴, David G. Meckes Jr.⁴, Yan Li², and Samuel C. Grant^1,2

¹National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, United States, ²Chemical & Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, FL, United States, ³University of California, Los Angeles, CA, United States, ⁴Department of Biomedical Sciences, Florida State University, Tallahassee, FL, United States

Synopsis

This study interrogates human mesenchymal stem cell (hMSC) derived treatments (cells versus secretome) in a preclinical transient ischemic stroke model. Biochemical markers of tissue recovery measured longitudinally over 21 d via sodium chemical shift imaging and proton relaxation-enhanced MR spectroscopy demonstrated that the arterial injection of extracellular vesicles produced in vitro by hMSC improved outcomes over ischemic stroke, albeit not to the level of direct cellular implantation. For the first time, novel MRI-compatible labeling provided the initial visualization of biodistribution and estimated permanence of hMSC-derived extracellular vesicles in the ischemic brain.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.